RecruitingNot applicableNCT06050200
TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
Studying Pediatric hepatocellular carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of Warsaw
- Principal Investigator
- Karolina Grąt, PhD, M.DMedical University of Warsaw
- Intervention
- PVE(procedure)
- Enrollment
- 154 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2024 – 2029
Study locations (1)
- Second Department of Clinical Radiology, Warsaw, Masovian Voivodeship, Poland
Collaborators
Medical Research Agency, Poland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06050200 on ClinicalTrials.govOther trials for Pediatric hepatocellular carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07295340Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC DetectionWest China Hospital
- RECRUITINGPHASE1NCT04715191Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsBaylor College of Medicine
- RECRUITINGNCT06669377TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.Zhongda Hospital
- ACTIVE NOT RECRUITINGNANCT07214363The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver CancersNational Taiwan University Hospital
- RECRUITINGNANCT05738980Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3Beijing Hospital
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05120271BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid TumorsSotio Biotech Inc.
- RECRUITINGNCT05517811Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGPHASE1NCT04377932Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsBaylor College of Medicine